Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

18.47 +0.51 (+2.84%)
Streaming Delayed Price Updated: 12:50 PM EDT, May 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
News headline image
NovoCure (NVCR) Q2 2024 Earnings Call Transcript ↗
NVCR earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
NVCR Stock Earnings: NovoCure Beats EPS, Beats Revenue for Q2 2024 ↗
NVCR stock results show that NovoCure beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Novocure Reports Second Quarter 2024 Financial Results
From Novocure
Via Business Wire
News headline image
Breaking Down NovoCure: 4 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Novocure to Report Second Quarter 2024 Financial Results
From Novocure
Via Business Wire
News headline image
A Closer Look at 7 Analyst Recommendations For NovoCure ↗
 
Via Benzinga
News headline image
Unveiling 8 Analyst Insights On NovoCure ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival
From Novocure
Via Business Wire
News headline image
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Why NovoCure Stock Soared 18.3% This Week ↗
Novocure announced encouraging results in a phase 3 trial for its TTFields therapy. 
Via The Motley Fool
News headline image
Why Novocure Stock Is Jumping Today ↗
Novocure had good news mixed with some not-so-good news. 
Via The Motley Fool
News headline image
Peeling Back The Layers: Exploring NovoCure Through Analyst Insights ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025 ↗
These stocks to buy are expected to double by 2025 and could turn mundane market returns into something bigger with a willingness to bet. 
Via InvestorPlace
News headline image
NovoCure (NVCR) Q1 2024 Earnings Call Transcript ↗
NVCR earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
NVCR Stock Earnings: NovoCure Beats EPS, Beats Revenue for Q1 2024 ↗
NVCR stock results show that NovoCure beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon
From Novocure
Via Business Wire
News headline image
Novocure Reports First Quarter 2024 Financial Results
From Novocure
Via Business Wire
News headline image
Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024
From Novocure
Via Business Wire
News headline image
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024
From Novocure
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Novocure to Report First Quarter 2024 Financial Results
From Novocure
Via Business Wire
News headline image
Novocure Stock Soars, Its Lung Cancer Electric Field Treatment Slows Progression To Brain, Data Shows ↗
Novocure's Phase 3 METIS trial results: TTFields therapy, combined with supportive care, significantly prolongs time to intracranial progression for NSCLC brain metastases patients compared to... 
Via Benzinga
News headline image
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday. 
Via Benzinga
Topics Stocks
News headline image
Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment ↗
The company uses electrical fields to interrupt the rampant cellular division characteristic of cancer. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
From Novocure
Via Business Wire
News headline image
INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO
From Novocure
Via Business Wire
News headline image
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.